Clinical Research Directory

Current Clinical Studies

Clinical Observation Trials

CONNECT_MM Study: For patients with newly diagnosed multiple myeloma

Biovica Divitum Study: For patients with HR+ Metastatic Breast Cancer


Clinical Treatment Trials

ABEMA Study: For patients with ER+ HER2- Early Breast Cancer

Therapy on Trial: Giredestrant and Abemaciclib

ASCENT-05 Study: For patients who completed chemotherapy followed by surgery

Therapy on Trial: Sacituzumab Govetican and Pembrolizumab

TAILOR Study: For patients who have not received treatment for their CLL

Therapy on Trial: Ibrutinib & Venetoclax OR Ibrutinib Alone

COCOON Study: For patients who have not received treatment for their locally advanced/metastatic EGFR mutated NSCLC

Therapy on Trial: Amivantamab & Lazertinib with dermatological medications

REC-4881-221 LILAC Study: For patients with an AXIN1 or APC mutation for locally advanced or metastatic cancer

Therapy on Trial: REC-4881 Drug

Past Studies

Essential Thrombocythemia Study

NCI-MATCH Study: Targeted therapy directed by genetic testing

INSIGHT_MM Study: For patients with multiple myeloma

ROMAN Study: For patients receiving chemoradiotherapy for head and neck cancer

REVEAL Study: For patients with polycythemia vera

To learn more about a specific clinical trial, please contact our Clinical Trial Coordinator by dialing 908.237.1201 extension 262 or email

About HHO

Hunterdon Hematology Oncology is a community oncology group, dedicated to fighting cancer in this community and across the region. Our Doctors, Physician’s Assistants and Nurses work tirelessly. They fight hard so that you can win.


Sign up for the HHO newsletter to stay up to date on the latest news within the practice and the community.

    © HHO 2022. All rights reserved. Designed by DRAW